Manager, FP&A - Commercial at Azurity Pharmaceuticals

Raleigh, North Carolina, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Analytical approach to financial modeling and reporting
Excellent communication skills with the ability to simplify and explain complex problems to non-finance colleagues
Deadline-driven, organized, and able to multi-task
Travel may be necessary 5-10% of the year
Bachelor’s Degree in Accounting or Finance
CPA or other relevant certifications preferred
3-5 years of relevant experience is required
Experience in the pharmaceutical industry (preferred)
Strong understanding of gross to nets (preferred)
Advanced Microsoft Excel skills (preferred)
Experience with Oracle Fusion (preferred)

Responsibilities

Partner and build trusted relationship with Commercial, North America leadership team
Lead detailed gross to net analysis and forecasting efforts
Model opportunities for gross to net optimization
Review monthly close results and provide leadership with explanations of variances, while developing action plans to support budget objectives
Partner with accounting team to ensure proper recording of multi-period activities
Lead the creation of monthly budget vs. actual variance reporting to highlight key risks and opportunities
Create and maintain monthly forecasts, annual budgets, and long-range planning activities
Review vendor contracts to ensure alignment with budget and business requirements
Provide support to the Director, FP&A North America with ad-hoc requests

Skills

FP&A

Budgeting

Forecasting

Financial Planning

Financial Analysis

Variance Analysis

Cross-functional Collaboration

Leadership

Commercial Finance

Business Planning

Azurity Pharmaceuticals

Develops specialized formulations of medicines

About Azurity Pharmaceuticals

Azurity Pharmaceuticals develops specialized formulations of existing medicines to meet the needs of patients who are often overlooked by traditional pharmaceutical companies. Their products include oral suspensions and other forms that are easier to administer, particularly for those who have difficulty swallowing pills or need precise dosing. This focus on creating accessible and effective medications enhances patient compliance and addresses gaps in the pharmaceutical market. Azurity serves healthcare providers, hospitals, and pharmacies, generating revenue through the sale of FDA-approved proprietary medicines across various therapeutic areas, including cardiovascular, central nervous system, and oncology. Their goal is to improve patient outcomes by providing high-quality, innovative medicines tailored to specific medical conditions.

Woburn, MassachusettsHeadquarters

2000Year Founded

$182.2MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Hybrid Work Options

Professional Development Budget

Tuition Reimbursement

Wellness Program

Risks

Product recalls, like Zenzedi's, can damage brand reputation and cause financial losses.

Integration challenges from Slayback Pharma acquisition may disrupt operations.

Reliance on FDA approvals means regulatory delays could impact product launches.

Differentiation

Azurity focuses on innovative dose forms for overlooked patient needs.

Their FDA-approved products ensure safety and efficacy in specialized formulations.

Azurity's acquisition of Slayback Pharma enhances its development and launch capabilities.

Upsides

Growing demand for personalized medicine aligns with Azurity's specialized dose forms.

Increasing chronic diseases boost need for Azurity's innovative drug delivery systems.

FDA's focus on novel formulations benefits Azurity's product pipeline.

Land your dream remote job 3x faster with AI

Try Jobo Free